Highlights from the last 2 years in Campy

It has been two years since the last major Campylobacter meeting, and there have been a number of exciting publications during that time. We have catalogued some of the highlights here.

Click a topic to see a list of publications:

• AMR
• Applied - vaccines, control strategies, feed additives, farms, chickens
• Clinical micro/outbreaks/epidemiology and public health
• Emerging Campylobacter species
• Global differences in Campylobacter epidemiology
• Host adaptation/evolution
• Immunology and Host response
• Pathogenicity and Virulence Factors
• Survival

Immunology and host response

• Guirado, P. et al. (2020) ‘Differential Distribution of the wlaN and cgtB Genes, Associated with Guillain-Barré Syndrome, in Campylobacter jejuni Isolates from Humans, Broiler Chickens, and Wild Birds’, Microorganisms, 8(3), p. 325. doi: http://doi.org/10.3390/microorganisms8030325.
• Heimesaat, M. M., Mousavi, S., Kløve, S., et al. (2020) ‘Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis’, Microorganisms, 8(6), p. 802. doi: http://doi.org/10.3390/microorganisms8060802.
• Heimesaat, M. M., Mousavi, S., Escher, U., et al. (2020) ‘Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study’, Microorganisms, 8(12), p. 1858. doi: http://doi.org/10.3390/microorganisms8121858.
• Kløve, S. et al. (2020) ‘Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10−/− Mice’, Microorganisms, 8(12), p. 1882. doi: http://doi.org/10.3390/microorganisms8121882.